Research
Excludes commercial-in-confidence projects.
Exploiting blood vessels as conduits for the entry of therapeutic CAR-T cells into brain tumours, Neurosurgical Research Foundation, 02/10/2023 - 31/10/2025
Development of a new therapy for glioblastoma based on chimeric antigen receptor (CAR)-T cells, Tour de Cure Ltd, 01/01/2021 - 31/12/2022
Checkpoint blockade immunotherapy in melanoma: getting tumour-killing T cells to their site of action, Royal Adelaide Hospital, 01/01/2016 - 31/03/2017
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included.
Open access indicates that an output is open access.
Year | Output |
---|---|
2025 |
Open access
|
2025 |
6
6
|
2024 |
|
2024 |
Open access
17
|
2024 |
Open access
3
2
4
|
2023 |
Open access
10
9
|
2023 |
Open access
16
15
|
2023 |
Open access
7
8
|
2023 |
Open access
1
1
|
2023 |
2
2
|
2023 |
Open access
20
17
|
2023 |
Open access
17
19
|
2022 |
Open access
64
60
|
2022 |
Open access
21
18
|
2022 |
Open access
32
29
4
|
2022 |
Open access
6
6
|
2022 |
Open access
1
|
2022 |
Open access
16
17
4
|
2021 |
Open access
77
75
|
2021 |
Open access
8
8
|
2021 |
Open access
35
29
|
2021 |
Open access
13
|
2021 |
1
1
1
|
2021 |
Open access
30
26
|
2021 |
Open access
51
48
|
2020 |
12
12
2
|
2020 |
Open access
51
46
4
|
2020 |
4
3
|
2020 |
Open access
12
13
|
2020 |
Open access
7
7
6
|
2020 |
9
10
|
2019 |
Open access
37
35
|
2019 |
29
30
|
2019 |
Open access
9
9
|
2019 |
14
13
|
2019 |
4
3
|
2019 |
121
114
9
|
2019 |
Open access
18
18
|
2019 |
Open access
19
20
|
2018 |
Open access
|
2018 |
Open access
75
71
|
2018 |
25
23
|
2018 |
Open access
76
68
|
2018 |
816
759
|
2018 |
Open access
10
9
10
|
2018 |
8
9
|
2017 |
33
28
|
2017 |
Open access
20
18
2
|
2017 |
Open access
376
343
|
2017 |
Open access
15
15
2
|
2017 |
|
2017 |
Open access
26
26
3
|
2016 |
10
10
1
|
2016 |
1
|
2016 |
Open access
38
30
|
2016 |
Open access
304
279
11
|
2016 |
Open access
43
43
1
|
2015 |
Open access
25
25
2
|
2015 |
100
87
|
2015 |
34
35
|
2015 |
12
10
|
2015 |
22
20
|
2014 |
Open access
300
271
|
2014 |
20
17
|
2014 |
Open access
2
2
|
2014 |
Open access
23
20
|
2013 |
Open access
66
56
|
2013 |
Open access
4
|
2013 |
Open access
154
141
|
2013 |
Open access
3
4
|
2013 |
Open access
22
22
|
2013 |
Open access
11
9
|
2012 |
Open access
80
77
|
2012 |
Open access
|
2012 |
7
7
|
2012 |
Open access
840
769
|
2012 |
7
7
|
2011 |
Open access
118
102
|
2011 |
1
1
|
2011 |
2
2
|
2011 |
Open access
21
20
|
2011 |
35
33
|
2011 |
16
16
|
2011 |
Open access
12
11
|
2011 |
Open access
60
60
|
2010 |
Open access
119
114
|
2010 |
Open access
5
5
|
2010 |
5
5
|
2010 |
Open access
11
11
|
2009 |
Open access
31
28
|
2009 |
37
37
|
2009 |
Open access
14
14
|
2009 |
58
56
|
2009 |
Open access
119
195
|
2009 |
32
28
|
2009 |
28
30
|
2008 |
10
7
|
2008 |
30
31
|
External engagement & recognition
Organisation | Country |
---|---|
Adelaide Cancer Centre | AUSTRALIA |
Adelaide Radiotherapy Centre | AUSTRALIA |
Angeles Clinic and Research Institute | UNITED STATES |
Austin Hospital | AUSTRALIA |
Australian National University | AUSTRALIA |
Bayer | UNITED STATES |
Baylor College of Medicine | UNITED STATES |
Bristol-Myers Squibb, US | AUSTRALIA |
Centro Oncologico de Rosario | ARGENTINA |
Clinical Network Services | AUSTRALIA |
Copenhagen University Hospital | DENMARK |
CSIRO Australia (Commonwealth Scientific Industrial Research organisation) | AUSTRALIA |
Department of Health | SOUTH AFRICA |
Duke University | UNITED STATES |
Eli Lilly | AUSTRALIA |
Erasmus University Rotterdam | NETHERLANDS |
Flinders Medical Centre | AUSTRALIA |
Flinders University | AUSTRALIA |
Garvan Institute of Medical Research | AUSTRALIA |
Genesis Care | AUSTRALIA |
GlaxoSmithKline | AUSTRALIA |
GPCR Therapeutics | KOREA, REPUBLIC OF (SOUTH) |
Griffith University | AUSTRALIA |
H. Lee Moffitt Cancer Center | UNITED STATES |
Hanson Institute | AUSTRALIA |
Harvard University | UNITED STATES |
Hebrew University | MEXICO |
Hospital Clinic Barcelona | SPAIN |
Hospital Universitario | UNITED STATES |
Houston Methodist Hospital | UNITED STATES |
Institute of Medical and Veterinary Science | AUSTRALIA |
InterVenn Biosciences | UNITED STATES |
Lipotek Pty Ltd | AUSTRALIA |
Ludwig Institute for Cancer Research | AUSTRALIA |
Mayo Clinic | UNITED STATES |
Melanoma Institute Australia | AUSTRALIA |
Monash University | AUSTRALIA |
Motherson Innovations Australia | AUSTRALIA |
Netherlands Cancer Institute | NETHERLANDS |
New York Medical College | UNITED STATES |
New York University | UNITED STATES |
Novartis Pharmaceuticals Corporation | UNITED STATES |
Nucleus Network | AUSTRALIA |
Olivia Newton-John Cancer Research Institute | AUSTRALIA |
Osaka Prefecture University | JAPAN |
Peter MacCallum Cancer Centre | AUSTRALIA |
Pfizer Oncology | UNITED STATES |
PharmAust | AUSTRALIA |
Pontifical Catholic University of Rio Grande do Sul (PUCRS) | BRAZIL |
Prince of Wales Hospital | AUSTRALIA |
Princess Alexandra Hospital | AUSTRALIA |
Private Individual | UNITED KINGDOM |
QIMR Berghofer Medical Research Institute | AUSTRALIA |
Queensland Institute of Medical Research | AUSTRALIA |
Roche Diagnostics | SWITZERLAND |
Royal Adelaide Hospital | AUSTRALIA |
Royal Brisbane and Women's Hospital | AUSTRALIA |
Royal Darwin Hospital | AUSTRALIA |
Royal Melbourne Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
Sarah Cannon Research Institute | UNITED STATES |
Sarcoma Research Group | AUSTRALIA |
Scientia Clinical Research Ltd | AUSTRALIA |
Seoul National University | KOREA, REPUBLIC OF (SOUTH) |
Sir Charles Gardiner Hospital | AUSTRALIA |
South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
Southern Medical Day Care Centre | AUSTRALIA |
Taipei Veterans General Hospital | TAIWAN |
TBG Diagnostics | AUSTRALIA |
The Alfred Hospital | AUSTRALIA |
The Queen Elizabeth Hospital | AUSTRALIA |
The Royal Marsden NHS Foundation Trust | UNITED KINGDOM |
University Clinic Schleswig-Holsteinl | GERMANY |
University Hospital Schleswig-Holstein | GERMANY |
University Medical Centre Freiburg | GERMANY |
University of Adelaide | AUSTRALIA |
University of British Columbia | CANADA |
University of Colorado Denver | UNITED STATES |
University of Freiburg | GERMANY |
University of Melbourne | AUSTRALIA |
University of New South Wales | AUSTRALIA |
University of Newcastle | AUSTRALIA |
University of North Carolina at Chapel Hill | UNITED STATES |
University of Pennsylvania | UNITED STATES |
University of Pittsburgh | UNITED STATES |
University of Pittsburgh Medical Center | UNITED STATES |
University of Queensland | AUSTRALIA |
University of South Australia | AUSTRALIA |
University of South Florida | UNITED STATES |
University of Sydney | AUSTRALIA |
University of Texas | UNITED STATES |
University of Utah | UNITED STATES |
University of Western Australia | AUSTRALIA |
University of Zurich | SWITZERLAND |
Utrecht University Medical Center | NETHERLANDS |
Vall d'Hebron University Hospital | SPAIN |
Virax Holdings Limited | AUSTRALIA |
Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
Yonsei University College of Medicine | KOREA, REPUBLIC OF (SOUTH) |
Zucero Therapeutics Ltd | AUSTRALIA |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Enhancing cancer immunotherapy success by efficient recruitment of T cells to solid tumours | Current |
Identifying optimal immunotherapy combinations for the treatment of brain tumours | Current |
Development and evaluation of ovine polyclonal antibody therapies for the treatment of severe influenza infection and bacterial sepsis | Completed |
Dissecting the mechanisms involved in the induction of immunity to recombinant fowlpox virus | Completed |
Evaluation of the immunomodulatory properties of dasatinib for improved application in combinatorial immunotherapy regimens | Completed |
Optimising CAR T cell manufacturing for solid cancers | Completed |
Preclinical development of GD2 CAR-T cell therapy for glioblastoma | Completed |
The use of biomaterials to investigate and modulate innate and adaptive immunity | Completed |
Vasculogenic mimicry: regulation and function in melanoma | Completed |